FULL PAPERS
Sandeep R. Kandukuri et al.
˜
(cyclohexane:ethyl acetate=2:1); IR (ATR): n=3457 (br),
1H NMR (400 MHz, CDCl3): d=1.01 (t, J=7.3 Hz, 3H),
1.44–1.51 (m, 1H), 1.90 (br s, 1H), 2.13–2.19 (m, 1H), 2.32–
2.41 (m, 2H), 3.01 (dd, J=8.8 Hz, J=4.6 Hz, 1H), 3.06 (dd,
J=15.6 Hz, J=2.1 Hz, 1H), 3.70 (s, 3H), 3.74 (d, J=4.7 Hz,
1H), 3.76 (s, 3H), 3.89 (s, 3H), 5.65 (d, J=15.5 Hz, 1H),
6.19 (d, J=0.9 Hz, 1H), 6.98–7.05 (m, 1H), 7.13 (ddd, J=
7.1 Hz, J=7.1 Hz, J=0.7 Hz, 1H), 7.31–7.34 (m, 2H), 7.57
(d, J=7.7 Hz, 1H); 13C NMR (126 MHz, CDCl3): d=13.7,
24.7, 33.4, 37.6, 43.0, 44.3, 51.4, 51.5, 75.6, 109.9, 112.0, 120.1,
120.6, 124.4, 124.6, 125.0, 126.7, 131.6, 141.1, 144.4, 144.6,
166.6, 167.2; HR-MS (APCI): m/z=398.1967, calcd. exact
mass for [M+H]+ (C23H28NO5): 398.1962.
2973 (w), 2924 (w), 1701 (s), 1595 (s), 1461 (m), 1364 (m),
1340 (m), 1263 (m), 1225 (m), 1151 (s), 1035 (s), 972 (m),
853 (m), 739 (s) cmꢀ1; H NMR (500 MHz, CDCl3): d=1.28
1
(t, J=7.2 Hz, 3H), 1.34 (t, J=7.2 Hz, 3H), 1.39 (d, J=
7.2 Hz, 3H), 2.14 (br s, 1H), 2.42 (dd, J=14.5 Hz, J=
7.8 Hz, 1H), 2.54 (ddd, J=14.5 Hz, J=8.0 Hz, J=1.2 Hz,
1H), 3.03 (d, J=14.7 Hz, 1H), 3.29 (q, J=7.0 Hz, 1H), 3.78
(d, J=14.7 Hz, 1H), 3.88 (s, 3H), 4.17 (q, J=7.2 Hz, 2H),
4.23 (dq, J=7.0 Hz, J=1.6 Hz, 2H), 5.76 (d, J=15.5 Hz,
1H), 6.20 (s, 1H), 7.09 (dd, J=15.7 Hz, J=7.7 Hz, 1H),
7.11–7.15 (m, 1H), 7.31–7.34 (m, 2H), 7.60 (d, J=7.9 Hz,
1H); 13C NMR (126 MHz, CDCl3): d=14.4, 14.5, 15.9, 33.2,
36.4, 37.2, 42.2, 60.3, 60.4, 75.3, 110.1, 113.4, 120.0, 120.1,
124.2, 124.8, 125.1, 125.7, 131.7, 141.2, 143.9, 144.3, 166.2,
166.8; HR-MS (APCI):
Ethyl
cis-(E,E)-4-[1-(2-ethoxy-2-oxoethylidene)-3-hy-
droxy-9-methyl-4-phenyl-2,3,4,9-tetrahydro-1H-carbazol-3-
yl]but-2-enoate (cis-18b, Table 3, entry 6): Prepared from
diethyl
(phenyl)methyl]nona-2,7-dienedioate
0.10 mmol, 1.0 equiv.), Pd(OAc)2 (2.3 mg, 10 mmol,
10 mol%), and Cu(OAc)2 (74 mg, 0.40 mmol, 4.0 equiv.) in
(2E,7E)-5-hydroxy-5-[(1-methyl-1H-indol-3-yl)-
m/z=412.2115, calcd. exact mass for [M+H]+ (C24H30NO5):
412.2118.
AHCTUNGTRENNUNG
(14b, 47 mg,
AHCTUNGTRENNUNG
Butyl
cis-(E,E)-4-[1-(2-butoxy-2-oxoethylidene)-3-hy-
AHCTUNGTRENNUNG
droxy-4,9-dimethyl-2,3,4,9-tetrahydro-1H-carbazol-3-yl]but-
2-enoate (cis-15c, Table 3, entry 3): Prepared from dibutyl
(2E,7E)-5-hydroxy-5-[1-(1-methyl-1H-indol-3-yl)ethyl]nona-
2,7-dienedioate (11c, 47 mg, 0.10 mmol, 1.0 equiv.),
THF (1.0 mL) according to GP2 at 808C for 72 h. Purifica-
tion by flash column chromatography on silica gel (cyclo-
hexane:ethyl acetate=3:1) afforded the analytically pure
product as a light brown oil; yield: 14 mg (30%). GLC (HP-
5): tR =34.0 min; Rf =0.25 (cyclohexane:ethyl acetate=2:1);
PdACHTUNGTRENNUNG(OAc)2 (2.3 mg, 10 mmol, 10 mol%), and CuCAHTUNGTREN(NUGN OAc)2
(74 mg, 0.40 mmol, 4.0 equiv.) in THF (1.0 mL) according to
GP2 at 808C for 72 h. Purification by flash column chroma-
tography on silica gel (cyclohexane:ethyl acetate=6:1) af-
forded the analytically pure product as a brown oil; yield:
38 mg (81%). GLC (HP-5): tR =37.5 min; Rf =0.55 (cyclo-
˜
IR (ATR): n=2918 (m), 2849 (m), 1713 (s), 1596 (m), 1461
(m), 1339 (m), 1258 (s), 1165 (m), 1092 (m), 1022 (s), 797
1
(s), 745 (s), 699 (s) cmꢀ1; H NMR (400 MHz, CDCl3): d=
1.28 (t, J=7.4 Hz, 3H), 1.34 (t, J=7.4 Hz, 3H), 1.63 (br s,
1H), 2.52 (dd, J=14.9 Hz, J=7.2 Hz, 1H), 2.60 (dd, J=
14.9 Hz, J=8.1 Hz, 1H), 3.34 (dd, J=14.9 Hz, J=0.9 Hz,
1H), 3.45 (d, J=14.9 Hz, 1H), 3.96 (s, 3H), 4.18 (q, J=
7.0 Hz, 2H), 4.23 (q, J=7.0 Hz, 2H), 4.42 (s, 1H), 5.83 (d,
J=15.6 Hz, 1H), 6.23 (d, J=1.3 Hz, 1H), 6.87–6.92 (m,
2H), 7.13 (dd, J=7.8 Hz, J=7.8 Hz, 1H), 7.17–7.21 (m,
3H), 7.28–7.32 (m, 4H); 13C NMR (100 MHz, CDCl3): d=
14.4, 14.5, 29.8, 31.1, 35.3, 37.7, 42.6, 61.4, 74.6, 108.4, 114.4,
120.0, 121.8, 122.3, 124.7, 124.9, 125.8, 127.8, 129.0, 129.5,
130.4, 131.2, 138.2, 144.1, 148.9, 166.7, 166.8; HR-MS
(APCI); m/z=474.2278, calcd. exact mass for [M+H]+
(C29H32NO5): 474.2275.
˜
hexane:ethyl acetate=2:1); IR (ATR): n=3499 (br), 2955
(w), 1705 (s), 1652 (m), 1461 (m), 1370 (m), 1258 (s), 1166
(s), 1062 (m), 1028 (m), 988 (s), 839 (w), 737 (s) cmꢀ1
;
1H NMR (400 MHz, CDCl3): d=0.94 (t, J=7.2 Hz, 3H),
0.91 (t, J=7.2 Hz, 3H), 1.38 (d, J=7.2 Hz, 3H), 1.39–1.47
(m, 4H), 1.61–1.71 (m, 4H), 2.42 (dd, J=14.5 Hz, J=7.2 Hz,
1H), 2.53 (ddd, J=14.5 Hz, J=7.9 Hz, J=1.1 Hz, 1H), 3.04
(dd, J=14.9 Hz, J=1.8 Hz, 1H), 3.29 (q, J=7.0 Hz, 1H),
3.79 (d, J=14.9 Hz, 1H), 3.88 (s, 3H), 4.11 (t, J=6.6 Hz,
2H), 4.17 (t, J=6.6 Hz, 2H), 5.76 (dt, J=15.6 Hz, J=
1.7 Hz, 1H), 6.20 (d, J=1.4 Hz, 1H), 7.08 (dd, J=15.6 Hz,
J=7.7 Hz, 1H), 7.11–7.16 (m, 1H), 7.31–7.34 (m, 2H), 7.60
(d, J=8.1 Hz, 1H); 13C NMR (126 MHz, CDCl3): d=13.9,
13.9, 15.9, 19.4, 29.8, 30.8, 30.9, 33.2, 36.6, 37.1, 42.2, 64.3,
64.3, 75.3, 110.0, 113.4, 120.0, 120.1, 124.2, 124.8, 125.1,
125.7, 131.7, 141.2, 143.9, 144.3, 166.3, 166.9; HR-MS
(APCI):
Butyl (E)-4-[1-(2-butoxy-2-oxoethyl)-4,9-dimethyl-9H-car-
bazol-3-yl]but-2-enoate (19c, Scheme 4): GLC (HP-5):
Yellow solid; yield: quantative; mp 89–918C. tR =39.8 min;
˜
Rf =0.55 (cyclohexane:ethyl acetate=2:1); IR (ATR): n=
2955 (w), 2870 (w), 1713 (s), 1648 (m), 1578 (w), 1465 (m),
1377 (w), 1321 (m), 1265 (s), 1156 (s), 1120 (m), 1062 (m),
m/z=468.2748, calcd. exact mass for [M+H]+ (C28H38NO5):
468.2744.
1023 (m), 983 (m), 730 (s) cmꢀ1 1H NMR (500 MHz,
;
Methyl
cis-(E,E)-4-[4-ethyl-3-hydroxy-1-(2-methoxy-2-
CDCl3): d=0.91 (t, J=7.3 Hz, 3H), 0.94 (t, J=7.3 Hz, 3H),
1.31–1.42 (m, 4H), 1.59–1.66 (m, 4H), 2.80 (s, 3H), 3.74 (dd,
J=6.1 Hz, J=1.3 Hz, 2H), 4.10 (s, 3H), 4.13 (t, J=6.7 Hz,
2H), 4.14 (d, J=7.3 Hz, 2H), 4.15 (s, 2H), 5.70 (dt, J=
15.6 Hz, J=1.9 Hz, 1H), 7.08 (s, 1H), 7.22 (dt, J=15.6 Hz,
J=6.4 Hz, 1H), 7.28 (dd, J=6.7 Hz, J=0.6 Hz, 1H), 7.44 (d,
J=8.3 Hz, 1H), 7.51 (dd, J=8.3 Hz, J=7.9 Hz, 1H), 8.27 (d,
J=8.0 Hz, 1H); 13C NMR (126 MHz, CDCl3): d=13.7, 13.8,
16.7, 19.2, 19.3, 30.7, 30.8, 32.1, 36.0, 39.0, 64.2, 65.1, 108.5,
114.2, 119.1, 121.9, 122.9, 123.5, 123.7, 125.3, 126.4, 131.2,
131.9, 138.7, 142.2, 148.1, 166.9, 172.2; HR-MS (APCI):
m/z=450.2645, calcd. exact mass for [M+H]+ (C28H36NO4):
450.2639.
oxoethylidene)-9-methyl-2,3,4,9-tetrahydro-1H-carbazol-3-
yl]but-2-enoate (cis-16a, Table 3, entry 4): Prepared from di-
methyl (2E,7E)-5-hydroxy-5-[1-(1-methyl-1H-indol-3-yl)pro-
pyl]nona-2,7-dienedioate (12a, 40 mg, 0.10 mmol, 1.0 equiv.),
PdACHTUNGTRENNUNG(OAc)2 (2.3 mg, 10 mmol, 10 mol%), and CuCAHTUNGTREN(NUGN OAc)2
(74 mg, 0.40 mmol, 4.0 equiv.) in THF (1.0 mL) according to
GP2 at 808C for 72 h. Purification by flash column chroma-
tography on silica gel (cyclohexane:ethyl acetate=4:1) af-
forded the analytically pure product as a light brown oil;
yield: 22 mg (55%). GLC (HP-5): tR =37.5 min; Rf =0.30
˜
(cyclohexane:ethyl acetate=2:1); IR (ATR): n=3502 (br),
2949 (w), 1702 (s), 1648 (m), 1430 (m), 1369 (w), 1325 (m),
1260 (s), 1163 (s), 1030 (m), 978 (m), 838 (w), 737 (s) cmꢀ1
;
12
ꢃ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 0000, 000, 0 – 0
ÝÝ
These are not the final page numbers!